A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI).
about
Spinal osteosarcomaThe epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investmentIntravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases.Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience.Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupPoor prognosis osteosarcoma: new therapeutic approach.A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomesPharmacotherapy of sarcoma.Metastatic osteosarcoma: a challenging multidisciplinary treatment.Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.Hollow chitosan–silica nanospheres for doxorubicin delivery to cancer cells with enhanced antitumor effect in vivo
P2860
Q26996533-141A557A-6561-441B-B89E-831785C38EA5Q33626004-8D08C068-19C0-4E04-9E78-11165C43CD85Q35958048-9C29E1CF-324B-4009-9280-0EF80FE145CBQ36478219-AC482A5B-77C0-4FF9-876A-7F0D04069553Q36556924-C96D8DB3-05A4-4990-A3DD-595A13CC9E18Q36613417-7BD7719B-4BB4-4F32-92DE-4786DDBADC47Q36946864-EAA0E606-477C-4F5A-AA0A-46535E8C2C74Q37188469-03AE1A74-461B-4014-A735-D60C273AF07CQ37232138-380659AC-BA91-440E-9B1F-9279CF9BD9A7Q37532566-D258302E-BAB6-4B12-AE9D-9D7A963B9C58Q38783252-130D5D6E-DCCF-440E-A6CA-0A6977AE3CACQ40697952-50A63B27-0555-4099-A247-9BBE16E7F4A0Q43968973-A184C31D-ED0B-4D28-B723-78B606C3AD1EQ57376374-1F6EFC89-8A3A-4B33-8A21-FFC3A7E78596
P2860
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI).
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@ast
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@en
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@nl
type
label
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@ast
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@en
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@nl
prefLabel
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@ast
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@en
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI).
@nl
P2093
P356
P1433
P1476
A phase II study of cisplatin, ...... Osteosarcoma Intergroup (EOI)
@en
P2093
A Kirkpatrick
B M Uscinska
H Cortés-Funes
J W van der Eijken
M van Glabbeke
R L Souhami
P304
P356
10.1023/A:1008361612767
P577
1999-10-01T00:00:00Z